Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History PSTV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics PSTV

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Plus Therapeutics Inc

PSTV
Current price
0.35 USD +0.001 USD (+0.29%)
Last closed 0.33 USD
ISIN US72941H4002
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 15 115 956 USD
Yield for 12 month -80.92 %
1Y
3Y
5Y
10Y
15Y
PSTV
21.11.2021 - 28.11.2021

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is REYOBIQ, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests, such as the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas. Address: 2710 Reed Road, Houston, TX, United States, 77051

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9.17 USD

P/E Ratio

Dividend Yield

Financials PSTV

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures PSTV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+5 824 000 USD

Last Year

+4 913 000 USD

Current Quarter

+1 059 000 USD

Last Quarter

Current Year

+4 972 000 USD

Last Year

-4 777 000 USD

Current Quarter

+878 000 USD

Last Quarter

EBITDA -14 218 000 USD
Operating Margin TTM -333.90 %
Price to Earnings
Return On Assets TTM -105.59 %
PEG Ratio
Return On Equity TTM -522.50 %
Wall Street Target Price 9.17 USD
Revenue TTM 5 206 000 USD
Book Value -1.39 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -36.90 %
Dividend Yield
Gross Profit TTM -4 367 000 USD
Earnings per share -2.78 USD
Diluted Eps TTM -2.78 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation PSTV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 18.19
Price Sales TTM 2.90
Enterprise Value EBITDA -0.30
Price Book MRQ 3.76

Technical Indicators PSTV

For 52 Weeks

0.16 USD 2.31 USD
50 Day MA 0.44 USD
Shares Short Prior Month 513 082
200 Day MA 1.00 USD
Short Ratio 0.10
Shares Short 1 165 867
Short Percent 3.57 %